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The interaction of cells with surrounding matrix and neighbouring cells governs many aspects of cell behaviour. Aside from transmitting
signals from the external environment, adhesion receptors also receive signals from the cell interior. Here we review the interrelationship
between adhesion receptors, tyrosine kinases (both growth factor receptor and non-receptor) and modulators of the actin cytoskeletal
network. Deregulation of many aspects of these signalling pathways in cancer highlights the need for a better understanding of the
complexities involved.
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1. General introduction (herein defined as regulated disassembly). Interestingly,In their physiological environment, cells are in contact
with surrounding extracellular matrix (ECM) and with
neighbouring cells. Cell adhesion receptors are key sensors
of cues that stem from the environment, thereby contributing
to both the adhesive process and to transmission of signals
that result in dependent cellular responses. Indeed, adhesion
receptors can modulate or activate intracellular signal trans-
duction pathways in a number of ways, for example, by
clustering in the membrane at adhesion sites, by recruiting
and interacting with adaptor proteins or proteins that link
adhesive structures to cellular cytoskeletal networks, or by
directly activating enzymatic proteins at the inner surface of
the plasma membrane. In addition to stimulating signal
transduction pathways, adhesion receptors are themselves
subject to regulation by intracellular signalling (often termed
‘inside-out’ signalling). In particular, they exist in protein
complexes that are dynamically regulated in response to
intracellular cues which specify complex formation, translo-
cation to the membrane sites of adhesion and turnover0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2004.04.010
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of adhesion complexes is cell migration, it is almost certainly
linked also to signal transduction output, even in the case of
adhesions that might appear rather static but are probably
continually adjusting adhesive and signalling properties
within localised regions of the cell membrane.
Cell migration requires continuous assembly and disas-
sembly of cell–ECM or cell–cell contacts, and constant
remodelling of the associated actin cytoskeleton. Commu-
nication and interaction between adhesion receptors and
polymerised actin is therefore essential for important cell
responses, such as migration and intracellular signalling that
controls cell growth and survival. It follows that there must
be tightly controlled functional interactions between adhe-
sion molecules and actin regulators which, in turn, allow
actin filaments to assemble. Included in the list of key actin
regulators that act in concert with adhesion receptors, or
their immediate binding partners, are the Rho family of
small GTPases, their effectors such as Diaphanous (Dia)
proteins or the serine-threonine kinase ROCK, and the
WASP/Scar family of adaptor proteins that link upstream
signals, including those from Rho proteins, to actin nucle-
ation via the Arp2/3 complex. Lipid and tyrosine kinases,
and their respective phosphatases, also contribute to the
complex regulation of actin organisation downstream of
V.G. Brunton et al. / Biochimica et Biophysica Acta 1692 (2004) 121–144122adhesion molecules. In addition to signals transduced to
actin and beyond, ligand-bound adhesion molecules can
induce traction on attached filamentous actin which results
in adhesion receptor clustering and concentration of partic-
ular signalling complexes into localised domains at the
membrane. Thus, bidirectional signalling occurs between
the actin cytoskeleton and adhesion molecules at the plasma
membrane and this coordinates and controls actin filament
assembly, cell adhesion and adhesion-dependent signalling.
Like assembly, localised disassembly of adhesive inter-
actions is a critical part of adhesion dynamics and cell
migration. This too is complex and involves multiple
signalling inputs. Importantly, both receptor and non-recep-
tor tyrosine kinases contribute to adhesion turnover and the
mechanisms are being identified by which tyrosine kinases,
and their effectors, suppress adhesive function and induce
disorganisation, or reorganisation, of the associated actin
cytoskeleton. Often this involves antagonism of the medi-
ators of actin assembly mentioned above; for example, the
Src tyrosine kinase can induce phosphorylation and activa-
tion of the p190Rho-GAP protein that antagonises RhoA, as
well as interfere with the RhoA–ROCK–LIM kinase path-
way that regulates actin filament assembly by modulating
the actin severing activity of cofilin. In addition, more direct
mechanisms of inducing de-adhesion also occur. Indeed, the
exact role of the Src family kinases (SFKs), and other
tyrosine kinases, is complex and is spatially regulated. As
will be discussed, engagement of some adhesion receptors
causes activation and recruitment of the same tyrosine
kinases, such as the SFKs, that ultimately cause disassembly
of the adhesion complexes into which they are recruited.
Such kinases simultaneously control actin/adhesion dynam-
ics and signal into the cell interior to link proliferation with
adhesion dynamics. While the precise contribution of indi-
vidual signalling proteins that control, and are controlled by,
adhesion receptors remains to be established, it is clear that
there are contributions from multiple spatially and tempo-
rally controlled adhesion-linked activities leading to pre-
cisely localised events that, in turn, produce the required
cellular responses.
In this article, we focus on the functional interplay
between mediators of cell–ECM adhesions (the integrins),
or cell–cell adhesions (the cadherins), and modulators of
actin dynamics. As tyrosine kinases are found at both
adhesion types, and are profoundly important as modulators
of both the adhesions themselves and the associated actin
cytoskeleton, we will emphasise the close, but complex,
three-way relations between the integrin and cadherin ad-
hesion receptors, tyrosine kinases and regulators of the actin
cytoskeleton.2. The integrin adhesion network
Integrins are transmembrane receptors which are concen-
trated at points of contact between cells and the ECM, wherethey associate with a number of structural and signalling
proteins and form a link with the actin cytoskeleton. The
regulation and activation of integrins are reviewed in detail
in other articles in this issue of BBA and will not be
discussed here. It is now well established that integrin
complexes both transmit signals to the cell interior as well
as receive signals from within the cell [1–5]. Key players in
this bidirectional signalling are the small Rho GTPases
RhoA, Rac1 and Cdc42 whose activities coordinate the
cytoskeletal changes required for directional cell movement
[6–8]. Rho GTPases act as molecular switches by cycling
between an inactive GDP-bound form and an active GTP-
bound form. The ratio of GTP-bound (active) or GDP-
bound (inactive) Rho GTPases is determined by three
distinct regulatory proteins: guanine nucleotide exchange
factors (GEFs), which enhance the exchange of bound GDP
for GTP; the GTPase activating proteins (GAPs), which
serve as negative regulators by increasing the rate of
intrinsic hydrolysis of bound GTP; and guanine nucleotide
dissociation inhibitors (GDIs), which inhibit both GTP
exchange and the hydrolysis of GTP.
Early studies reported dramatic changes in the cellular
actin cytoskeleton after integrin engagement and this was
subsequently attributed to activation of Rac1 or Cdc42.
Rac1 and Cdc42 activation leads to localised actin poly-
merisation at the cell periphery with the resultant formation
of lamellipodia or filopodia, respectively [6]. Cell motility is
driven by this localised actin polymerisation at the leading
edge of cells, where new actin subunits are added to the
barbed ends of actin filaments. Filopodia consist of long
bundles of unbranched actin filaments that are formed by a
process of treadmilling whereby elongation occurs at the
barbed end or filopodial tips, and actin monomers are
released from the pointed end. In lamellipodia, there is a
branched network of actin filaments with new filaments
growing outwards towards the membrane, resulting in the
forward propulsion of the cell [9]. The Arp2/3 complex is a
seven-protein complex which acts as a nucleator of actin
filaments on preexisting actin filaments, and initiates growth
of filaments at 70j to each other forming the branched
dendritic network found at the leading edge of motile cells.
The Arp2/3 complex itself is inactive and members of the
Wiskott–Aldrich syndrome protein (WASP)/Scar family of
adaptor proteins have been identified as downstream effec-
tors of Rac1 and Cdc42 which bind to the Arp2/3 complex
and enhance the nucleation activity of the complex [10]. To
date, five WASP/Scar family members have been identified,
WASP, N-WASP, Scar1, Scar2 and Scar3, which all contain
a highly conserved carboxy-terminal tail consisting of a so-
called VCA domain. This is made up of a verprolin region
(V), also known as WASP homology (WH) domain which
binds actin monomers, a connecting sequence (C) and the
terminal acidic (A) domain which binds the Arp2/3 com-
plex. These domains are sufficient to activate Arp2/3
nucleation activity. WASP and N-WASP are autoinhibited
due to an intramolecular interaction between the GTPase
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molecule and the C region of the VCA domain [11]. This
autoinhibition is released by phosphatidylinositol 4,5-
bisphosphate (PIP2), activated Rho GTPases and adaptor
proteins such as Grb2 and Nck [12]. The Scar proteins lack
a GBD domain and are not autoinhibited within the cell;
rather, their activity is regulated by a multi-protein complex
where Scar exists in an inactive state while complexed with
HSPC300, PIR121 and Nap125. Activated Rac1 and Nck
can dissociate Scar–HSPC300 from the complex which is
able to activate the Arp2/3 complex and actin nucleation
[13]. Lamellipodia and filopodia are associated with the
assembly of small focal contacts which are sites of new
immature adhesions with the ECM and are required to
stabilise the lamellipodia during migration. As the cell
moves forward, these adhesion sites develop into larger
focal adhesions behind the base of the lamellipodia under
the control of RhoA. RhoA stimulates actomyosin-based
contractility required for the assembly of stress fibres and
focal adhesions [14]. The transition between focal complex
and focal adhesion is thought to provide an adhesive force
required for traction during cell migration at the leading
edge [15,16].
Thus, Rho GTPase signals from within the cell initiate
clustering of integrins at the cell surface with the resultant
formation of focal adhesions and complexes, which in turn
act as signalling centres. Early studies on the regulation of
the small GTPases demonstrated that their activation was
controlled by migratory growth factors such as platelet-
derived growth factor (PDGF) and epidermal growth factor
(EGF), so positive feed back loops can be envisaged linking
growth factor and integrin signalling pathways. Initial mi-
gratory cues, resulting in activation of Cdc42 and Rac1 at the
leading edge of the cell, can initiate formation of new focal
complexes, activation of integrins and further activation of
Rac1, thus maintaining the actin polymerisation required for
cell movement. A direct link between the Arp2/3 complex,
actin polymerisation and integrins has now been established
which involves the transient association of the focal adhesion
protein vinculin with the Arp2/3 complex at newly forming
adhesions [17]. This is Rac1-dependent and probably
recruits the Arp2/3 complex to sites of integrin clustering.
Furthermore, the Arp2/3 regulator N-WASP is also present in
integrin complexes [18].
Directional cell movement relies on cues from a number
of different signalling pathways and in this regard coordi-
nation of signals from integrins and growth factors is
closely linked to differential activation of the individual
Rho GTPases. Numerous examples now exist confirming
the importance of cross talk between integrins and other
signalling pathways such as receptor tyrosine kinases
(RTKs), which will be discussed later. Initially we will
consider the role of the non-receptor tyrosine kinases Src
and Abl in modulating signalling pathways that link
integrin complexes at the cell periphery to changes in
the actin cytoskeleton.2.1. How activated Src influences integrins and actin
function
Integrin engagement, perhaps in cooperation with RTKs,
causes activation and recruitment of Src (or other SFKs) to
peripheral signalling complexes. As will be discussed, Src
activity contributes positively to adhesion signalling and
consequent cellular responses; however, constitutive activa-
tion of Src tyrosine kinases can also suppress integrin
function and cause actin disruption in a number of ways.
Although the latter are largely attributed to the constitutive
activity of activated Src mutants, they might reflect mech-
anisms that are normally controlled by endogenous Src.
Thus, the relationship between SFKs and integrin function
is complex; activation of Src following integrin engagement
can then lead to feedback loops whereby Src mediates
integrin signalling to actin modulators at a number of
different levels, such as direct phosphorylation of integrins,
regulators of Rho GTPases and modulators of actin poly-
merisation (Fig. 1).
2.1.1. Activation of SFKs by integrins
Integrin engagement induces tyrosine phosphorylation of
a large number of proteins, many of which are Src substrates
(focal adhesion kinase (FAK), cortactin, p130Cas, Shc,
paxillin, tensin) [19–23], and experiments with Src/Yes/
Fyn null cells indicate that the SFKs are required to initiate
many of integrin-mediated tyrosine phosphorylation events
[20]. Recently, a model for integrin-dependent activation of
SFKs has been proposed from work on h3 integrin hetero-
dimers found in osteoclasts and platelets [24]. Specifically,
Src binds to the cytoplasmic face of the h3 subunit in an
association which involves the Src SH3 domain. It is
thought that this pool of Src is primed for activation.
Following integrin clustering, the local concentration of
Src is increased which leads to trans-autophosphorylation
and activation of the kinase. Dissociation of Csk, a negative
regulator of Src, from the integrin complex could also
contribute to stabilisation of Src activation [25]. This may
form the basis of a more general mechanism for integrin-
mediated Src activation as other Src family members also
associate with other h-integrin subunits [24]. Interestingly,
in squamous carcinoma cells, Fyn associates with the h6
subunit of avh6 and is activated upon integrin engagement.
This, in turn, is linked to activation of a pathway that
enhances matrix metalloproteinase production and tumour
metastases in mice [26]. Thus, association of distinct Src
family members with different integrin subunits may pro-
vide tight control of cell type specific signalling and
deregulation of either specific integrins or SFKs during
tumourigenesis may therefore have marked effects on cel-
lular behaviour.
PTPa is another key regulator of SFK activation follow-
ing integrin-mediated adhesion. PTPa is a receptor tyrosine
phosphatase which dephosphorylates tyrosine-527 in Src,
and the equivalent residues in Fyn and Yes [27–30]. This
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Fig. 1. Src coordinates signals from RTKs and integrins leading to changes in Rho GTPase activity, adhesion dynamics and cytoskeletal rearrangements. A
number of components of these pathways are directly regulated by Src-induced phosphorylation. For example, phosphorylation of FAK leads to its degradation
by calpain, which is important for integrin adhesion disassembly, while phosphorylation of WASP enhances its ability to induce actin nucleation via the Arp2/3
complex. Cross talk between integrin and RTK pathways also occurs at a number of different levels—cortactin is phosphorylated in response to both RTK and
integrin engagement and can directly influence actin nucleation within the cell. Reciprocal activation of integrin clustering and the small GTPases Rac and
Cdc42 lead to amplification of signals from the external environment and provide an additional level of complexity. The ultimate decision of a cell to move will
be governed by a number of factors including the relative abundance of key components of these pathways and their spatiotemporal regulation.
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a resulting activation of the kinase. Cells lacking PTPa have
reduced activity of SFKs and defects in integrin signalling
with a resultant inhibition of cell spreading [31]. Interest-
ingly PTPa associates with avh3 integrin during early
spreading and this is required for the activation of SFKs,
particularly Fyn, assembly of focal complexes and strength-
ening of the link between the integrin and underlying matrix
[32]. Overexpression of PTPa has been found in breast
carcinomas and in late stage colon carcinomas; although it is
not known what the SFK status is in these tumours, it is
tempting to speculate that the increased activity of Src in
these tumour types may be related to dephosphorylation by
PTPa.
2.1.2. Direct phosphorylation of integrin subunits
v-Src can directly phosphorylate h-integrin subunits,
including h1A and h3 integrin, and suppress their activity.
For example, activated Src phosphorylates two tyrosines inthe intracellular tail of expressed h1A-integrin. Mutation of
these not only suppresses v-Src-induced focal adhesion and
actin stress fibre loss in transformed fibroblasts, but also
causes a general increase in focal contact number and ECM
deposition in untransformed cells. This implies that Src
normally suppresses h1-integrin function, dynamic turnover
of associated focal contacts and matrix deposition [33].
However, tyrosine phosphorylation of endogenous h1A-
integrin has not been detected, perhaps due to the presence
of a coupled serine phosphorylation site close by or because
it occurs only transiently [33]. The effects of activated Src
on a5h1-integrin, the major fibronectin receptor, are less
clear. However, Src-induced weakening of a5h1-integrin–
fibronectin links is probably due to indirect effects such as
causing fibronectin ligand to become inaccessible to cell
surface integrin [34]. As a result, ‘outside-in’ signalling
normally downstream of fibronectin–integrin interactions,
as judged by tyrosine phosphorylation of FAK, does not
occur in Src-transformed cells and proliferation becomes
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phosphorylated by activated Src; in this case, there is a more
direct weakening of cell–fibronectin links mediated by
avh3-integrin [35].
These findings indicate that activated Src has negative
effects on h1- and h3-integrin function. For both h1- and
h3-integrins, it is proposed that tyrosine phosphorylation by
endogenous Src may be part of a regulated cycle of
phosphorylation and dephosphorylation that contributes to
dynamic assembly and disassembly of focal adhesion com-
plexes, which, in turn, is needed to maintain integrin–
matrix and integrin–cytoskeleton links, as well as signalling
downstream. It is therefore possible that at appropriate times
after cell–ECM interaction, endogenous Src coordinates
weakening of adhesive links with termination of adhesion-
induced, integrin-dependent signalling.
2.1.3. R-Ras
Another mechanism by which Src activity may cause
feedback to suppress integrin function is by direct phos-
phorylation of R-Ras, the Ras family member that controls
integrin activity (defined as the binding affinity of integrins
for their matrix ligands [36]; reviewed in this issue of BBA
by P. Keeley). Specifically, activated Src proteins can
associate with R-Ras and induce phosphorylation on tyro-
sine-66 that is linked to the ability of R-Ras to support
integrin activity [37]. Furthermore, mutation of tyrosine-66
of R-Ras partially reverses Src-induced suppression of cell
adhesion [37]. Thus, R-Ras phosphorylation by Src may
represent a normal mechanism controlling cell adhesion and
integrin activity.
2.1.4. Talin
Talin, a component of focal adhesions, has recently
emerged as a key regulator of adhesion dynamics. It acts
by stabilizing ECM–integrin–actin links and promoting
signalling downstream of active integrins. Structure/func-
tion studies have revealed that talin responds to ‘inside-out’
signalling by causing a conformational change in integrins
and increasing integrin affinity [38] (reviewed in Ref. [39]).
The effects of talin are mediated by its FERM domain
interacting with the integrin h-cytoplasmic domain, and
Tadokoro et al. [38] have shown that ‘inside-out’ signals
from multiple sources, including R-Ras, converge on talin.
Furthermore, talin, like many focal adhesion proteins, is
probably regulated by a conformational change such as that
induced by binding PIPKIg and resulting localised PIP2
production, or through cleavage by the calpain protease to
expose cryptic binding sites for integrins and other protein
partners [40–43]. While the details of major regulatory
events upstream and downstream of talin integrin activity
remain to be worked out, talin is an identified substrate for
Src’s catalytic activity. Furthermore, Src-mediated phos-
phorylation of the phosphatidylinositol phosphate kinase,
PIPKIg, increases the binding affinity of PIPKIg to the talin
head domain, so inhibiting h-integrin binding [41], therebyindirectly effecting integrin function. The precise mecha-
nisms by which talin responds to the coordinated activities
of both non-receptor tyrosine kinases, RTKs and integrins,
or is linked to control of the actin polymerisation/depoly-
merisation cycle, will almost certainly be revealed in the
near future.
2.1.5. p190 RhoGAP
Oncogenic Src causes disruption of the actin cytoskele-
ton, at least in part, by inactivation of RhoA via tyrosine
phosphorylation of p190 RhoGAP [44]. p190 RhoGAP is a
RasGAP-associated protein that is tyrosine-phosphorylated
in v-Src transformed cells [45]. It has a GAP domain at its
carboxy terminus that is specific for Rho proteins, particu-
larly RhoA. Activation of v-Src induces binding of tyrosine-
phosphorylated p190 RhoGAP to p120 RasGAP and stim-
ulation of p120 RasGAP associated RhoGAP activity [46].
These events require the catalytic activity of Src and are
linked to stress fibre disruption during transformation. An
activated form of RhoA, which is insensitive to RhoGAP
activity, suppresses v-Src induced stress fibre loss and
transformation, indicating that v-Src must antagonise the
function of RhoA to induce actin disruption [47]. Integrin
engagement induces early Src-mediated tyrosine phosphor-
ylation and activation of p190 RhoGAP resulting in inhibi-
tion of RhoA activity [48]. This is followed by a more
prolonged activation of RhoA [49]. The initial suppression
of RhoA activity may relax contractility at sites of integrin
adhesion, allowing protrusion of polarised structures at the
leading edge of motile cells. Thus, although sufficient RhoA
activity is required for the generation of contractile forces,
localised antagonism of RhoA-mediated contractility is
probably also required in migrating cells. Consistent with
this, integrin-induced inhibition of RhoA by p190 RhoGAP
enhances spreading and migration by regulating membrane
protrusion and polarity [50]. In neuronal cells, Src-mediated
phosphorylation of p190 RhoGAP is required for integrin-
mediated neurite outgrowth and a number of the develop-
mental neuronal defects seen in p190 RhoGAP / mice
resemble those seen in Src/Fyn mutant mice [51]. Src-
mediated tyrosine phosphorylation of p190 RhoGAP is also
important for the cytoskeletal changes associated with
growth factor signalling. For example, EGF-induced actin
rearrangements in fibroblasts requires the Src-dependent
phosphorylation of p190 RhoGAP [52,53]. Interestingly,
p190 RhoGAP may also have tumour suppressor functions
in cancer cells. In glial cells, p190 RhoGAP expression
results in reduced RhoA activity and is accompanied by
decreased incidence of PDGF-induced oligodendrogliomas
in mice [54]. Interestingly, 40% of human gliomas show
loss of the chromosomal region encompassing p190 Rho-
GAP [55].
2.1.6. Disruption of the Rho–ROCK–LIM kinase pathway
Activated Src also interferes with Rho GTPase signalling
via MEK-induced disruption of signalling downstream of
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readout of the RhoA–ROCK–LIM kinase pathway that
regulates actin filament assembly, Pawlak and Helfman
[56] showed that Src-induced suppression of RhoA signal-
ling can occur at the level of ROCK or LIM kinase, as
expression of active forms of either restores actin stress
fibres in Src-transformed NRK cells. This indicates that Src
can interfere with RhoA signalling at a number of different
levels in the pathway.
2.1.7. Regulation of GEF activity
Another aspect of Rho GTPase signalling which Src may
regulate is in the activation of Rho GEFs. The best charac-
terised of these are the Vav proteins which are members of
the Dbl family of proto-oncogenes. These contain Dbl and
pleckstrin homology (PH) domains and act exclusively on
the Rho family of GTPases [57]. Vav proteins are regulated
by tyrosine phosphorylation which increases their exchange
activity by a mechanism thought to involve unmasking of the
Dbl domain and increased affinity of Vav towards its
substrate (reviewed in Ref. [58]). Initial experiments showed
that SFKs could phosphorylate Vav proteins in vitro leading
to increases in Rac1 activity [59] and more recently, Src-
mediated phosphorylation of Vav2 in cells has been associ-
ated with fibronectin induced activation of Rac1 and lamel-
lipodia formation [60]. However, integrin-mediated
phosphorylation of Vav2 may be cell type-specific or require
other tyrosine kinases such as Syk [61,62]. Indeed, phos-
phorylation of Vav1 in haematopoietic cells after integrin
engagement is Src-dependent [63]. The Vav proteins are also
phosphorylated in response to growth factor stimulation, and
PDGF-induced Vav2 phosphorylation is Src-dependent [64].
Other Dbl family GEFs, GRF1, FGD1 and Tiam1, are
also phosphorylated by SFKs [65–67]. Src potentiates
Tiam1-induced Rac1 activation leading to both activation
of transcription and membrane ruffling [67]. Since many
effects of Rac1 and Src overlap, such as induction of c-myc
expression [64], this suggests that Src-induced tyrosine
phosphorylation of individual Rac1 GEFs may act down-
stream of Src to mediate biological effects. For example,
RTKs may use Src to activate exchange factors for Rac1,
with the nature of the stimulus determining which particular
Rac1 GEF is tyrosine-phosphorylated and activated. Such
specificity may come from regulation of temporal and
spatial proximity between individual SFKs and particular
Rac1 GEFs after growth factor or integrin activation. In this
way, SFKs could phosphorylate and activate the appropriate
Rac1 GEF leading to localised Rac1 activation, lamellipodia
formation and downstream signalling. In addition, strong
Src-dependent activation of Rac1 may effectively suppress
the biological consequences of RhoA in cells, perhaps
contributing negatively to actin stress fibre assembly, cellu-
lar contractility and integrin clustering. Thus, Src-mediated
activation of Rac1 GEFs may contribute to cell adhesive-
ness and adhesion-dependent signalling by altering the
balance of Rac1 and RhoA activities within cells.Interestingly, Tiam1-deficient mice are resistant to Ras-
induced skin tumours and point to a role for Tiam1/Rac1
signalling in cell survival and tumour growth [68]. More
recent studies have linked breast cancer cell migration and
invasion with Tiam1/Rac1-mediated cytoskeletal changes
involving the cytoskeletal protein ankyrin [69]. Taken
together with the observation that both Tiam1 and Vav2
are highly phosphorylated in Src transformed cells [67], and
the elevated levels of SFKs in late stage tumours [70,71],
this suggests that Rho GEFS and SFKs may jointly con-
tribute to malignant conversion. Although it is not known
whether tyrosine phosphorylation of Tiam1 contributes to
tumourigenesis, it is found to be phosphorylated in breast
cancer cells after treatment with heregulin [72].
2.1.8. Phosphatases, SFKs and Rho GTPase regulation
Although much is known about the tyrosine phosphory-
lation events, and the kinases responsible, the importance of
protein tyrosine phosphatases regulating integrin adhesion is
now also becoming apparent [73]. A number of phospha-
tases are important for cytoskeletal rearrangements and cell
migration including PTPa (discussed above), PTP-PEST
which affects Rac1 activity, possibly via regulation of Vav
phosphorylation, and PTEN, a dual specificity phosphatase
which can also alter Rac1 and Cdc42 activity by its ability
to dephosphorylate phospholipids. The cytosolic PTP SHP-
2 (SH2-domain-containing protein tyrosine phosphatase 2)
requires membrane localisation for its activity and this is
mediated by binding of the SHP-2 SH2 domain to RTKs,
cytokine receptors and phosphorylated docking proteins
such as SHPS-1/SIRP-a1 [74]. SHPS-1 is tyrosine-phos-
phorylated by Src and associates with SHP-2 in response to
integrin activation [75]. SHP-2 regulates integrin signalling
and cell motility in a number of different systems. SHP-2
dephosphorylates p190-B RhoGAP that is phosphorylated
in response to insulin-like growth factor (IGF) treatment
[76]. Regulation of RhoA activity though may be context-
dependent since modulation of SHP-2 activity can lead to
both activation and inhibition of RhoA [77–79]. However,
SHP-2 is also targeted to lipid rafts—membrane micro-
domains where signalling molecules are concentrated, from
which it regulates RhoA activity and subsequent down-
stream signalling [80]. Interestingly, the localisation of
SHP-2 is dependent on SFKs but subsequent activation of
downstream signalling pathways is not. Thus, SFKs may
control the activity of SHP-2 by regulating its localisation
within the cell although a feedback loop involving activa-
tion of SFKs at integrin sites by SHP-2 may also exist
possibly via a mechanism involving dephosphorylation of
the Csk targeting protein Cbp [81,82].
2.1.9. Diaphanous proteins
mDia (murine Diaphanous) proteins are homologues of
Drosophila diaphanous and members of the formin homol-
ogy family of proteins that control nucleation of actin
filaments (reviewed in Ref. [83]). mDia1 and mDia2 are
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stress fibre assembly, as well as for cytokinesis and tran-
scriptional activation of serum response factor (SRF [84]).
Furthermore, mDia proteins appear to act as an interface
between RhoA and Src kinase signalling, since both mDia
and Src co-localise and form a complex, and Src inhibition
blocks cytokinesis, mDia-induced SRF activation and
mDia’s ability to co-operate with ROCK and induce stress
fibre assembly [84]. Recent evidence indicates that a newly
identified splice variant of human Dia, hDia2C, binds the
endosome-regulating Rho GTPase RhoD and co-operates
with active Src to drive actin-dependent endosome move-
ment [85]. Endosome cycling between the plasma mem-
brane and the perinuclear region, controlled by Rho
GTPases, Dia proteins and actin polymerisation/remodelling
events, almost certainly contributes to assembly of adhesion
receptor complexes. The use of fluorescence-based probes
and the development of appropriate biosensors will reveal
the hierarchy of protein–protein interactions during assem-
bly of such complexes, and the role of mDia in delivering
them to adhesion sites at the cell periphery.
2.1.10. Interplay between FAK and Src during regulation of
integrin–cytoskeletal signalling
FAK, which is reported to bind the intracellular regions
of h-integrin subunits, plays a pivotal role as a signal
integrator downstream of cell–ECM interactions and other
receptor and non-receptor tyrosine kinases (for a compre-
hensive review on FAK structure and function, gained by 10
years of research since its discovery as a Src substrate, see
Ref. [86]). Here we limit discussion to FAK’s role in linking
adhesion- and tyrosine kinase-induced signals to actin
regulation and actin-dependent responses such as cell mi-
gration. Clearly though, many of these events may also be
linked to the role of FAK in other processes, such as
suppression of anoikis or regulation of cell cycle progres-
sion and survival.
FAK responds to integrin engagement by autophosphor-
ylation of its tyrosine-397 which, in turn, creates a binding
site for the Src family kinases. Subsequent Src-dependent
phosphorylation events generate binding sites for a number
of interacting proteins that link FAK to downstream signal-
ling pathways, such as the Ras/ERK cascade, PI 3-kinase,
phospholipase C-g, and others (reviewed in Ref. [86]). In
addition, paxillin interacts with sequences in the focal
adhesion targeting domain of FAK close to its carboxy-
terminus, while proline-rich sequences in the carboxy-ter-
minal half of FAK bind to p130Cas, as well as regulators of
Rho and Arf GTPases. The association of FAK with
p190Rho-GEF (a RhoA-specific exchange factor found in
neuronal cells), GRAF (a RhoA-specific GTPase activating
protein) and ASAP1 (a GTPase activating protein for Arf1
and Arf6) may provide important links between activated
integrins and actin/adhesion remodelling, as well as in
control of intracellular trafficking events, such as those that
contribute to adhesion receptor complex assembly at theplasma membrane. In addition, another proline-containing
sequence, which is amino-terminal to the FAK tyrosine-397
autophosphorylation site, binds to the protease calpain2,
which is present at focal adhesions [87,88] and mediates
FAK- and Src-dependent adhesion turnover [88]. In normal
and Src-transformed embryonic fibroblasts, FAK acts as a
critical adaptor protein to recruit calpain2, and its upstream
activator p42ERK/MAP kinase to membrane adhesion sites.
Calpain activity is able to cleave a number of components of
focal adhesions, including FAK itself and talin, leading to
loss of structural links between integrins and the tethered
actin cytoskeleton and consequent disruption of focal adhe-
sion structures [88]. In keeping with this role for calpain, it
has emerged that loss of cellular calpain activity, like loss of
SFKs and FAK, impairs cell migration [88–90].
FAK contributes to the processes involved in cell migra-
tion and invasion in many ways, including promoting
formation of a FAK–p130Cas–Crk–DOCK180 complex
that leads to activation of Rac1 at the membrane, perhaps
via the Rac1 exchange factor ELMO ([91,92]; FAK recruit-
ment of this complex is reviewed in detail by D. Schlaepfer
in this issue of BBA). Paxillin may also target Rac1
effectors to FAK complexes, for example, by recruiting a
complex of PAK (p21-activated kinase), PIX (a PAK-
interacting guanine-nucleotide exchange factor), and PKL
(an Arf GTPase activating protein) via a leucine-rich repeat
in the paxillin sequence. Proper localisation of this complex
is essential for control of leading edge lamellipodia forma-
tion and focal adhesion turnover, and overexpression of the
leucine-rich domain that recruits the complex inhibits di-
rectional migration [93]. In addition, activated PAK is
recruited to newly forming focal complexes by paxillin
and contributes to actin and adhesion dynamics by phos-
phorylation of key regulators such as myosin light chain
kinase and LIM kinase [94]. Like FAK, paxillin is also a Src
substrate, and it appears that tyrosine phosphorylation can
regulate assembly of at least some paxillin-associated com-
plexes (reviewed in Ref. [95]). However, the complete role
of tyrosine phosphorylation in regulating the assembly and
function of paxillin-interacting complexes remains to be
established.
FAK is tyrosine-phosphorylated by activation of RTKs,
G-protein coupled receptors and chemokines (reviewed in
Ref. [96]). In fact, FAK is a pivotal integrator of signals
from RTKs and integrins. For example, FAK forms a
complex with the PDGF receptor and phosphorylation of
FAK on tyrosine-397 forms a binding site for SFKs that is
required for PDGF-induced migration [97]. Also, vascular
endothelial growth factor (VEGF) promotes Src-induced
phosphorylation of FAK and the formation of an avh3
integrin complex that is required for endothelial vascular
permeability [98]. FAK also forms a complex with activated
EGF receptor and is needed for EGF-induced cell migration
[97]. Interestingly, FAK and its homologue Pyk2 differ in
this regard, since Pyk2 does not associate in the same way
with the EGF receptor [97]. Thus, FAK recruits SFKs to
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actin/adhesion remodelling associated with cell migration
and signalling downstream of integrins that controls addi-
tional cell responses.
Recent evidence implies a role for Rac1 and PAK in
coordinating growth factor and integrin signalling. Specif-
ically, adhesion induces re-localisation of Rac1 to the
membrane, activation of PAK [99] and subsequent signal-
ling to ERK by stabilizing MEK1/ERK complexes [100].
Recent evidence indicates that adhesion-dependent phos-
phorylation of PAK, and then MEK1, on particular serine
residues requires the activities of Src and FAK [101],
indicating that adhesion- and mitogen-induced signalling
converge at the level of MEK1.
2.1.11. SFKs and regulators of the Arp2/3 complex
2.1.11.1. WASP/Scar. Key activators of the Arp2/3 com-
plex are the WASP/Scar family of proteins and there is now
a substantial body of evidence implicating the SFKs in the
regulation of WASP and N-WASP. Tyrosine phosphoryla-
tion of WASP has been reported in response to a number of
stimuli, including engagement of B cell antigen receptor
[102], aggregation of the IgE receptor in mast cells [103],
SDF-1a treatment of T cells [104] and collagen treatment of
platelets [105,106]. The site of phosphorylation has been
mapped to WASP tyrosine-291 [102,107] and N-WASP
tyrosine-256 [108]. These two tyrosine residues are within
the GBD of the WASP proteins and form part of a consensus
sequence for SFKs and the Src family members Hck and
Fyn mediate phosphorylation at these sites [107,108]. Phos-
phorylation of either WASP or N-WASP leads to increased
actin nucleation in vitro and enhanced neurite outgrowth
and filopodial formation in mast cells, confirming the
importance of phosphorylation to actin polymerisation
events within the cell [107,108]. An early study in mast
cells suggested that the phosphorylation of WASP by the
Src family kinase Lyn was regulated by Cdc42 [103] and a
model has emerged where efficient phosphorylation of
tyrosine-291/tyrosine-256 requires prior activation of an
autoinhibited conformation of WASP by Cdc42 or PIP2
[108,109]. The phosphorylated WASP proteins have higher
basal activity towards Arp2/3 and can promote actin nucle-
ation. In addition to destabilisation of the autoinhibited
conformation of WASP, the phosphorylated tyrosine pro-
vides a binding site for the SH2 domain of SFKs. The
association of Src SH2 domains to phosphorylated WASP
can further enhance activation of the Arp2/3 complex [109].
Previously, SFKs have been shown to bind to WASP
proteins via their SH3 domains [110,111] and Torres and
Rosen [109] demonstrated that a Src SH3-SH2 protein could
further enhance activation of the Arp2/3 complex, perhaps
by increasing the local concentration of Src SH2 domain at
the phosphorylated tyrosine-291 residue. Thus, the phos-
phorylation of WASP by SFKs provides a mechanism
whereby the initial activation of WASP by activatedCdc42 or PIP2 can be amplified and results in a ‘primed’
WASP protein which can react rapidly to further activation
signals.
More recently, serine phosphorylation of WASP has been
shown to be important in its regulation whereby phosphor-
ylation at serine-483 and -484 in the VCA domain by the
ubiquitous serine/threonine kinase CK2 increases the affin-
ity for the Arp2/3 complex. This phosphorylation is required
for efficient actin polymerisation by the full length WASP
molecule [112], while the equivalent residues in N-WASP
are also phosphorylated [112].
The phosphorylation sites identified as critical regulators
of WASP function are not conserved in their Scar homo-
logues. Scar proteins undergo an electrophoretic mobility
shift in response to PDGF treatment which reflects hyper-
phosphorylation although this is not on tyrosine residues
[113]. The hyperphosphorylation is sensitive to inhibition of
the MEK pathway although the importance of this to PDGF-
induced membrane ruffling is not known. Although the
importance of tyrosine phosphorylation in the regulation
of the Scar proteins is not known, both Scar 1 and 2 are
tyrosine-phosphorylated in cells where Src is overexpressed
(H. Ardern, V. Brunton, unpublished data).
2.1.11.2. Cortactin. More recently, the actin filament
binding protein cortactin has also been identified as an
activator of the Arp2/3 complex [114,115]. Cortactin has
an amino-terminal acidic domain which associates with the
Arp2/3 complex and a series of tandem repeating segments
that bind to F-actin. F-actin binding is essential for the
activation of Arp2/3. Unlike WASP/Scar, cortactin cannot
bind monomeric actin and this may explain why it is only a
weak activator of the Arp2/3 complex when compared to the
WASP/Scar family of proteins. Support for this comes from
experiments which show that association of cortactin with
WASP-interacting protein (WIP) can enhance Arp2/3 acti-
vation [116]. WIP was first identified as a regulator of N-
WASP-mediated actin polymerisation and filopodia forma-
tion [117]. WIP binds to monomeric actin and also to the
SH3 domain of cortactin, and co-expression of cortactin and
WIP results in formation of membrane protrusions, suggest-
ing a role for this interaction in regulation of actin dynamics
[116]. WASP and cortactin simultaneously bind to the Arp2/
3 complex through interactions with different components
of the complex; this results in synergistic activation of actin
nucleation perhaps by stabilisation of different conforma-
tions of the Arp2/3 complex [118].
Cortactin was first identified as a tyrosine-phosphory-
lated protein in v-Src transformed cells [119,120]. Experi-
ments in cells lacking Csk, the negative regulator of SFKs,
where either Src or Fyn was also absent, revealed that
phosphorylation of cortactin is largely dependent on Src
kinase [21]. Several studies support a role for Src in growth
factor and integrin-mediated phosphorylation of cortactin,
although there is also evidence that the non-receptor
tyrosine kinase Fer and the c-Met receptor can phosphor-
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poetic tyrosine kinase Syk is important for cortactin phos-
phorylation during platelet activation [121,122]. There are
three tyrosine phosphorylation sites in cortactin (tyrosine-
421, -466 and -482) localised within the proline-rich region
and tyrosine phosphorylation of tyrosine-421 may act as a
phosphoacceptor site for the SH2 domain of Src [123].
Cortactin phosphorylation is important for cell motility as
mutation of these three tyrosine phosphorylation sites leads
to impaired migration of endothelial cells [124]. More
specifically, Src-induced phosphorylation has been linked
to fibroblast growth factor (FGF)-induced motility of fibro-
blasts [125] and hyaluronan-induced migration of an ovar-
ian cancer cell line [126], while a cooperative role between
Fyn and cortactin has been proposed during the migration
of melanoma cells [127].
Although it is not clear how phosphorylation of cortactin
impinges on Arp2/3 activation, the localisation of both Src
and phosphorylated cortactin in lamellipodia following
growth factor-induced Rac1 activation [123,128] suggests
that it may act indirectly to recruit other regulators of actin
dynamics to sites of actin polymerisation. For example, the
SH2 domains of the adaptor proteins Nck and Crk both
associate with cortactin in Src transformed cells [129]. Nck
can activate actin nucleation through activation of Scar [13]
and also acts synergistically with PIP2 to activate N-WASP
[130]. The ability of Nck to bind tyrosine-phosphorylated
receptors may provide a further link between growth factors
and the actin cytoskeleton. This, taken together with the
ability of cortactin to bind proteins such as the CD2-
associated protein (CD2AP) via its SH3 domain in response
to EGF [131], supports a role for cortactin in linking
migratory growth factors and dynamic regulation of the
actin cytoskeleton. Interestingly, the SH3 domain of cortac-
tin also binds to N-WASP [132], which may participate in
recruitment of N-WASP to the Arp2/3 complex and enhance
actin nucleation as described above.
It has been long known that Src transformation results in
the replacement of focal adhesions with podosomes, sites of
adhesion containing a number of proteins found in focal
adhesions [133]. These are areas of particularly active actin
remodelling in cells and are the predominant actin structures
in macrophages and osteoclasts. In Src transformed cells,
they are associated with sites of matrix degradation
[132,134]. Cortactin redistributes to podosomes in Src
transformed cells [120] and the appearance of podosomes
in tumour cells overexpressing cortactin implies a role for
cortactin in podosome formation, which may be linked to a
more invasive and aggressive tumour [135]. The EMS1
gene that encodes cortactin is located on chromosome
11q12, a region commonly amplified in breast cancer and
other cancers, and which has been linked to poor prognosis
[136]. Cortactin expression is commonly enhanced in
tumours, and in experimental models this has been shown
to increase the migration, invasion and metastatic capacity
of tumour cells [124,127,137,138]. Although the mecha-nism whereby elevated expression of cortactin potentiates
metastasis [137] is not fully understood, it may be linked to
the ability of cortactin to regulate actin dynamics through
effects on the Arp2/3 complex. N-WASP also accumulates
in podosomes in v-Src transformed cells and dominant
negative mutants of N-WASP, which cannot activate Arp2/
3, suppress formation of podosomes and matrix degradation
[132]. As described above, cortactin may act in concert with
N-WASP to optimally activate the Arp2/3 complex at
podosomes while the presence of Src may act to recruit
N-WASP [110,111], both of which may result in increased
matrix degradation required for tumour cell invasion and
metastasis. This is supported by studies in a colon cancer
cell line in which overexpression of Src results in the
formation of podosomes where both activated Src and
phosphorylated cortactin localise along with the metallopro-
teinase MMP2 (Fig. 2; V.J. Fincham, unpublished data). The
overexpression and phosphorylation of cortactin also corre-
lates with metastatic potential in melanoma cells [127], and
raises the possibility that tumour types in which both Src
and cortactin are often overexpressed may be likely to
progress to a more invasive and metastatic tumour.
2.2. The Abl tyrosine kinase and actin function
The tyrosine kinase Abl can be activated by a variety of
stimuli that include growth factor and adhesion receptors
(Abl structure, modes of activation, including relief from
structural-based inhibition, and functions are reviewed ex-
tensively in Ref. [139]). Abl responds to growth factors and
cell adhesion by re-localising (in some cases from the
nucleus) to dynamic actin structures at the leading edges
of migrating cells. Abl and the related gene product, Arg,
bind to F-actin, and this is regulated by the adherent state of
the cell [140]. Abl is associated with F-actin in suspension,
whereas cell attachment and spreading result in dissociation
of F-actin and Abl and a concomitant increase in Abl
activity [141]. Furthermore, Abl regulates actin structures,
for example by inducing Src-dependent and Rho family
GTPase-independent F-actin microspikes and cell spreading
[142]. A membrane pool of Abl is activated after PDGF or
EGF treatment of fibroblasts by a mechanism that depends,
at least in part, on the activity of SFKs which can also
phosphorylate Abl in vitro [143]. It is proposed that Abl
autophosphorylation and Src-induced tyrosine phosphoryla-
tion of Abl cause independent and additive activation of Abl
[144]. Taken together with the finding that PDGF-induced
membrane ruffling does not occur normally in Abl-deficient
fibroblasts, the data indicate that Abl is a downstream
effector of PDGF receptor and Src activities in causing
altered actin re-modelling at the cell periphery [143].
Interestingly, fibroblasts deficient in Abl or Arg display
increased association between the Crk and p130Cas adaptor
proteins [145] that is associated with cell migration, prob-
ably by coupling adaptor protein complexes to Rac1-spe-
cific GEFs (such as DOCK180 [146]), and subsequent Rac1
Fig. 2. Src induces phosphorylation of cortactin and podosome formation. Expression of activated Src (c-SrcY527F) in KM12C colon cancer epithelial cells
results in the formation of podosomes which are dynamic actin-rich structures on the basal cell surface. Here we show localisation of phospho-cortactin (green),
counterstained with cortactin (red) at podosomes (right hand panel). Cells which do not express activated Src (left hand panel) have no detectable staining with
the phospho-cortactin antibody with cortactin being diffusely distributed throughout the cytoplasm. The schematic shows the typical architecture of podosomes
which consists of a central actin-rich core where components of the Arp2/3 complex as well as its activators WASP and cortactin have been found. Integrin
heterodimers anchor the podosomes to the surrounding ECM and structural proteins such as talin, vinculin and paxillin are found with integrins on the outer
ring of the podosomes. Metalloproteinases are also associated with podosomes, and in the KM12C cells expressing activated Src, the podosomes correspond
with areas of matrix degradation and most likely represent a mechanism whereby epithelial cells can invade into the surrounding stroma.
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promote Crk-p130Cas coupling and enhance cell migration,
indicating that the catalytic activity of Abl is required for
turnover, or suppressed assembly, of adaptor protein com-
plexes. Thus, Abl is a negative regulator of cell migration
[145], yet immortalised Abl- and Arg-deficient fibroblasts
display slightly impaired cell migration, reflecting the
complex and imperfectly understood roles for Abl in cell
migration [147]. In contrast to Abl, the oncogenic Bcr–Abl
fusion protein is clearly able to stimulate cell migration
(reviewed in Ref. [148]).
As well as growth factors like PDGF, integrin engage-
ment also activates Abl [149,150]. For example, cross-
linking a5h1 integrins results in activation of Abl [149].
Soon after fibronectin stimulation, Abl relocates to focal
adhesions and membrane filopodia, and associates with
paxillin and Grb2 [151], where it contributes to peripheral
actin remodelling and signalling into the cell interior (such
as to the ERK pathway [150]). A particular function of Abl
has been attributed to filopodial formation during cellspreading, perhaps suggesting a role in the way the cell
senses the environment.
The nature of key effectors of Abl during cell responses
to growth factors or adhesion receptors is not well estab-
lished. However, adaptor molecules like Crk, Nck (which
associates with Abl), the Scar adaptor proteins and the
Abl-interacting proteins Abi1/2 are all likely candidates.
Abi1/2, in particular, are binding partners and substrates of
Abl found at the tips of lamellipodia in metastatic cells
[152], and these are present in an actin nucleating mem-
brane complex with Scar1 and Nck-interacting proteins
after PDGF stimulation [13] (Fig. 3). Interestingly, Abi
proteins mediate functional interactions between Abl tyro-
sine kinases and Ena/VASP proteins that promote lamelli-
podia and filopodia formation by associating with the
barbed ends of actin filaments to promote filament elon-
gation (reviewed in Ref. [153]). Another potential effector
of Abl-mediated actin reorganisation is PSTPIP, a cyto-
skeletal-associated protein that undergoes Abl-dependent
tyrosine phosphorylation [154]. PSTPIP can interact with
Fig. 3. Regulation of the Scar/Abi complex. Scar is maintained within the cell in an inactive complex with HSPC300, PIR121, NAP125 and Abi proteins. To
enable it to respond rapidly to incoming signals resulting in actin nucleation, it must therefore be ‘primed’ for activation. Rac-GTP, through direct binding to
PIR121, can release Scar (along with HSPC300) from this multi-protein complex, which is then able to activate the Arp2/3 complex and thereby initiate de
novo actin nucleation. The Scar–HSPC300 complex is thought to then be targeted for proteolysis, thus preventing prolonged and aberrant activation of the
Arp2/3 complex. The adaptor protein Nck can also activate Scar by inducing breakdown of the Scar complex and is also thought to link RTK signalling to
Arp2/3 activation. The Abl tyrosine kinase also feeds in to these pathways as it can bind both Abi proteins and Nck and is activated in response to both integrin
and RTK signals. Many of these associations have been identified in isolation and it remains to be determined whether they do act in concert to regulate Scar
and the Arp2/3 complex in migrating cells.
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PEST to reverse phosphorylation of Abl itself, or WASP,
leading to modulation of actin structures [155]. As well as
these direct routes to actin modulation, Arg can phosphor-
ylate p190 RhoGAP in neuronal cells, leading to associ-
ation with p120 RasGAP and enhanced p190 RhoGAP
activity that suppresses RhoA functions (reviewed in Ref.
[148]). Although it is not known if Abl can modulate p190
RhoGAP, or whether such a mechanism operates in non-
neuronal cells, this also has the potential to induce changes
in actin organisation.3. The cadherin adhesion network
While cell–matrix adhesions are largely integrin-based,
cell–cell junctions are mediated by adherens junctions
(AJs), tight junctions and desmosomes. Cadherin-based
AJs provide the initial means of cell–cell contact and have
key roles during development and maintenance of epithelial
polarity. Additionally, there is overwhelming evidence that
the AJ is an important tumour and/or invasion suppressor
[156–158]. Like cell–matrix adhesions, AJs are intimately
associated both physically and functionally with the actin
cytoskeleton. Similarly, AJs are dynamically regulated sitesof bidirectional signalling which regulate and are regulated
by the actin cytoskeleton [159,160].
E-cadherin, the prototypic classical cadherin, is ubiqui-
tously expressed in epithelial tissues. In common with other
classical cadherins, E-cadherin is a single pass trans-mem-
brane protein with an extracellular domain consisting of five
extracellular repeats that mediate calcium-dependent homo-
typic interactions with the cadherin molecules of an adjacent
cell [161]. The cadherin cytoplasmic domain contains two
distinct and non-overlapping binding domains by which it
interacts with members of the armadillo family of catenin
proteins. In addition to these central components, AJs asso-
ciate with a variety of receptor and non-receptor kinases and
phosphatases, small GTPases, lipid kinases and components
of the actin assembly machinery. h-Catenin and plakoglobin
share significant homology and bind to a distal stretch of
approximately 30 amino acids known as the catenin-binding
domain (CBD). In turn, these proteins link the complex to the
actin cytoskeleton via a-catenin, a-actinin and related pro-
teins. In addition to their mechanical bridging role, h-catenin
and plakoglobin have also been implicated in cellular signal-
ling via the well-described wnt h-catenin–Tcf/Lef-1 path-
way [162]. A fourth catenin, p120-catenin (hereafter referred
to as p120), binds to a highly conserved region of approxi-
mately 10 amino acids within the cadherin juxtamembrane
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Src substrate whose tyrosine phosphorylation correlated with
transformation [167] and was subsequently defined as a
catenin [168–170] and the prototypic member of a new
subfamily of armadillo proteins [171]. The central role of
p120 at the AJ has only recently begun to be elucidated; by
regulating cadherin trafficking, p120 acts as a controller of
cell surface cadherin levels and hence cell–cell adhesions
[172–175]. Like h-catenin, p120 exists in membrane, cyto-
plasmic and nuclear fractions. The relative proportions of
these reflect the particular cellular context and are likely to
have profound effects on phenotype. Unlike h-catenin and
plakoglobin, p120 does not appear to physically link the AJ to
the cytoskeleton [176].
3.1. Regulation of the adherens junction
AJs are not static but rather must be amenable to rapid
remodelling, for example during embryogenesis or wound
healing. Even in a confluent epithelial monolayer, there is a
continual endocytosis and recycling of cadherin molecules,
albeit to a lesser extent than in sub-confluent cells [177].
The regulation of AJ formation and stability may be
influenced both by signals acting on junctional components,
and by signals originating from the nascent junction itself.
3.1.1. The cytoskeletal network and regulation of the
adherens junction
The development of intercellular adhesions requires not
only cadherin-mediated cell–cell contact, but also the
coordinated reorganisation of the actin cytoskeleton. The
earliest event in cell–cell contact is the redistribution of E-
cadherin from a diffuse membrane localisation to discrete
puncta with the formation of the so-called ‘adhesion zipper’
[178]. This consists of E-cadherin/catenin complexes linked
to the actin cytoskeleton that form punctate structures
perfectly opposed with identical structures on the adjacent
cell [179,180]. Ultrastructural studies show these puncta to
consist of actin-rich filopodia which become embedded in
the opposing plasma membrane with AJs located at points
of contact [180]. Over a period of hours the individual
puncta merge and a continuous zone of adhesion is formed.
Extensive actin reorganisation is involved in this process,
ultimately resulting in a circumferential actin ‘cable’ inter-
connecting cells throughout the entire epithelial sheet.
VASP, Mena, and the Arp2/3 complex are recruited to
puncta consistent with those being sites of actin polymeri-
sation [180,181]. Blocking actin polymerisation by interfer-
ing with VASP/Mena function does not inhibit the initial
puncta forming but prevents conversion of these structures
into broad adhesions [180]. Furthermore, formin-1 localises
to AJs where it binds to a-catenin and initiates the nucle-
ation of linear actin cables required for junction stability
[182]. Intact a- and h-catenin are also essential for the
formation of stable AJs via recruitment of the actin cyto-
skeleton to cadherin contacts.Although p120 does not bridge the cadherin molecule to
the actin cytoskeleton, its normal function and localisation
may also be essential. For example, cadherin-deficient
MDA231 or A431D cells expressing p120-uncoupling E-
cadherin mutants are unable to reorganise cortical actin into
a peripheral cable structure and adhesiveness is weakened
when compared to wild-type cadherin-expressing cells
[165]. In keratinocytes N-terminally deleted p120 acts in a
dominant negative manner to prevent conversion of puncta
into mature cell–cell junctions [183].
The requirement for actin reorganisation in the devel-
opment of cell–cell adhesions is consistent with observa-
tions implicating the Rho GTPases in adhesion formation
[184,185]. Blocking endogenous RhoA or Rac1 function
in keratinocytes, or MDCK cells, is associated with a
reduction in actin at sites of cell contact and an inability
to form stable AJs [186,187], while expression of acti-
vated Rac1, or of its exchange factor, Tiam-1, is sufficient
to block hepatocyte growth factor (HGF)-induced cell
scattering in MDCK cells, probably by increasing AJ
stability [188]. Likewise, Tiam-1 prevents Src-induced
AJ disassembly in MDCK cells [189].
Mechanisms by which RhoA and Rac1 may influence
AJs remain to be fully elucidated. Interestingly, Rac1
appears to localise specifically at the newest areas of
cell–cell contact rather than established contacts, suggesting
that a key role may be to promote local actin remodelling,
driving a rapid increase in the area of cell–cell contact and
hence the quantity of potential cadherin interactions [190].
One possible downstream effector of Rac1 in this regard is
IQGAP1. This protein localises to cell–cell junctions where
it competitively inhibits the interaction of a-catenin with h-
catenin, resulting in weakening of the cadherin–actin cyto-
skeleton link [191]. Activated Rac1 prevents the interaction
of IQGAP-1 with h-catenin and therefore strengthens cell–
cell adhesion [192]. Sahai and Marshall [193] have identi-
fied two downstream effectors of RhoA with opposing
effects on AJs. First, mDia-dependent actin polymerisation
stabilises AJs and second, ROCK-mediated actomyosin
contractility disrupts AJs. Which pathway predominates
may depend on the level of Rho activity and on the
expression of particular Rho family members. For example,
RhoC appears to preferentially activate the ROCK pathway
[193]. Finally, RhoA activates Fyn by a mechanism involv-
ing the Rho effector PRK2, and this is a prerequisite for AJ
formation in keratinocytes [194].
3.1.2. Phosphorylation and regulation of the adherens
junction
The tyrosine phosphorylation of specific junctional com-
ponents could provide an efficient means by which to
rapidly regulate the formation and disassembly of AJs.
Indeed, the tyrosine phosphorylation of various catenins
by receptor and non-receptor tyrosine kinases has been
associated with both positive and negative changes in
adhesion. However, the extent of tyrosine phosphorylation
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kinases and tyrosine phosphatases. Both receptor and non-
receptor tyrosine phosphatases interact with and dephos-
phorylate AJ components [195–200]. In keeping with this,
the ectopic expression of protein tyrosine phosphatases
favours cell–cell adhesion and inhibits motility in vitro,
and tumour formation in nude mice [201,202].
The major tyrosine kinase substrates within the AJ are
p120, h-catenin and plakoglobin [203] and these are all
phosphorylated in newly forming AJs [204,205]. Keratino-
cytes in mice with a disruption of the fyn and src genes have
reduced phosphorylation of p120 and h-catenin and are
defective in AJ formation [204], while expression of dom-
inant negative Src suppresses the turnover of adhesions
[206]. It therefore appears that phosphorylation events
mediated by endogenous SFKs may be required for the
normal function of AJs. In contrast, phosphorylation of AJ
components by oncogenic Src and by RTKs is generally
associated with disruption of cell–cell adhesion, loss of
epithelial differentiation and increased invasiveness [207–
211]. p120 is heavily phosphorylated in Src transformed
cells [167] and in response to EGF, PDGF, colony stimu-
lating factor-1 (CSF-1) and VEGF [212–214]. The amino-
terminal region of p120 contains the sites of Src-dependent
tyrosine phosphorylation [215] and most sites of serine/
threonine phosphorylation [216]. The consequences of p120
phosphorylation are not fully understood. However, several
observations suggest, albeit indirectly, that phosphorylated
p120 may act as a negative regulator at the AJ. For example,
overexpression of p120 which lacks the amino-terminal
region, and hence the phosphorylation domain, rescues
cell–cell adhesion in certain cell lines in which p120 is
constitutively hyperphosphorylated [217]. Moreover, the
reduction in cell–cell adhesion in E-cadherin-expressing
L-cells co-transfected with v-Src is prevented by the simul-
taneous overexpression of an N-terminally deleted p120
mutant [218].
Similarly, h-catenin and/or plakoglobin are phosphory-
lated in v-Src transformed cells [207,219] and in response to
EGF [209,210,220,221], HGF [209], transforming growth
factor-a (TGF-a) [222] and IGF-1 [223]. Phosphorylation
of E-cadherin typically occurs to a lesser extent but may
nevertheless be important [224].
Several lines of evidence suggest that phosphorylation
alters the affinity of AJ components for their cognate
binding partners resulting in weakening or severing of the
cadherin–cytoskeleton link. For example, treatment of cells
with the phosphatase inhibitor pervanadate induces a loss of
cell–cell aggregation which is associated with phosphory-
lation of h-catenin and plakoglobin and dissociation of a-
catenin from the AJ complex [225]. However, phosphatase
treatment has no effect when wild-type E-cadherin is
replaced with an E-cadherin–a-catenin chimera, thus pre-
venting dissociation of a-catenin from h-catenin. However,
in a similar model, v-Src remains able to reduce adhesion in
cells expressing an E-cadherin–a-catenin chimera, indicat-ing that disruption of the E-cadherin–h-catenin–a-catenin
chain is not a necessary event for AJ disruption [226].
Phosphorylated h-catenin is also reported to dissociate from
AJs [227–229]. Specific phosphorylation of h-catenin on
tyrosine-654 and tyrosine-142 is responsible for reducing its
affinity for cadherin and a-catenin, respectively [229,230].
Conversely, tyrosine phosphorylation of p120 increases its
affinity for E-cadherin [168,204,205,228–231].
p120 is constitutively associated with Fer and Fyn, both
of which can phosphorylate h-catenin at Tyr-142 [230,232].
p120 also recruits activated Yes, which in turn activate Fer
and Fyn, suggesting a role for p120 as a docking protein
acting to increase local tyrosine kinase activity [230]. A
further level of regulation is suggested by the differential
effects of tyrosine phosphorylation on h-catenin and pla-
koglobin [233]. Tyrosine-643 and tyrosine-133 of plako-
globin are functionally equivalent to h-catenin tyrosine-654
and -142, respectively. While Src could phosphorylate
plakoglobin tyrosine-643 with a concomitant reduction in
affinity for E-cadherin, the kinases Fer and Fyn did not
phosphorylate tyrosine-133. Instead they targeted tyrosine-
549 whose phosphorylation is linked to increased affinity
for a-catenin.
The recent identification of Hakai, a novel E3 ubiquitin
ligase, provides a further mechanism of tyrosine kinase-
mediated AJ disruption [224]. Following Src activation,
Hakai specifically binds the JMD of phosphorylated E-
cadherin, targeting it for ubiquitination and endocytosis
with a resulting decrease in cell–cell adhesion. Another
pathway linking Src to cadherin endocytosis involves the
ARF6 GTPase [234]. A dominant negative ARF6 mutant
blocks internalisation of E-cadherin in MDCK cells in
response to calcium depletion, HGF signalling or following
the activation of a temperature-sensitive v-Src mutant.
3.2. Cadherin-activated signalling: Rho GTPases/PI
3-kinase
The formation of AJs in response to calcium addition to
MDCK cells results in the recruitment of PI 3-kinase, its
phosphorylation, and activation of the PI 3-kinase/Akt
signalling pathway [235]. Rac1 is also recruited to AJs
where it is activated; the activation, but not recruitment, of
Rac1 is PI 3-kinase-dependent [236]. These events could be
blocked by an E-cadherin neutralising antibody, and are
clearly cadherin-dependent. However, it is not clear whether
they are truly cadherin-activated; specifically, whether cad-
herin engagement simply functions to bring cell membranes
into apposition with signalling events arising from addition-
al cell surface receptors interacting with ligands on the
adjacent cells. To clarify this, several groups have developed
model systems where by cadherin-expressing cells are
plated at low density in the absence of serum onto an
artificial surface expressing recombinant cadherin extracel-
lular domains [237–239] (recently reviewed in Refs.
[240,241]). This approach has shown that cadherin engage-
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that these result in the coordinated changes in the actin
cytoskeleton required for the formation of stable AJs.
The two signalling molecules most implicated in actin
remodelling are the small GTPase Rac1 and PI 3-kinase
which are activated and co-localise with AJ components at
nascent contacts following cadherin engagement [242]. A
p120-uncoupling mutation in the E-cadherin juxtamem-
brane domain prevents recruitment or activation of Rac1
and the formation of stable adhesions in response to
cadherin engagement [243]. This suggests a role for p120
in cadherin-mediated Rac1 activation. In addition, N-cad-
herin-expressing myogenic C2 or S180 cells plated on a
recombinant N-cadherin substrate typically undergo two
distinguishable responses [244]. First, the induction of
lamellipodia associated with new actin assembly, which is
PI 3-kinase- and Rac1-dependent. Second, the PI 3-kinase-
independent/Rac1-dependent reorganisation of N-cadherin,
catenins and actin filaments into ‘cadherin adhesions’ lo-
cated at the tips of lamellipodia. Silencing of p120 by RNAi
prevents both lamellipodial extension and cadherin complex
formation from occurring. Additionally, enforced expression
of p120 has an inhibitory effect, apparently by inhibition of
Rac1, and this is prevented by sequestration of p120 at the
membrane by a JMD construct. Thus, membrane-localised
p120 is essential for the activation of Rac1 by cadherin
engagement and an excess of cytoplasmic p120 may inhibit
this activation, perhaps by sequestering Rac1 GEFs.Fig. 4. Fak and p120 integrate signals at sites of adhesion. FAK and p120 act as sig
roles in coordinating the cellular response to adhesion receptor engagement or
adhesions influences its ability to regulate adhesion turnover and cell migration. A
disassembly which may also be regulated by phosphorylation events. Like FAK, p1
the actin cytoskeleton.3.3. p120 and regulation of Rho family GTPases
The first suggestion that p120 may act in concert with
Rho family GTPases to regulate the actin cytoskeleton came
from the phenotype of NIH3T3 fibroblasts forced to over-
express p120 [245]. This results in formation of character-
istic long branching processes indicative of actin
remodelling. Subsequently, Noren et al. [247] and Grosheva
et al. [246] independently demonstrated that overexpression
of p120 results in loss of actin stress fibres and focal
adhesions, acquisition of a dendritic phenotype and in-
creased cell motility. Critically, this phenotype is suppressed
by co-transfection of cells with dominant negative Rac1 or
Cdc42 and is exacerbated by expression of dominant
negative RhoA. Affinity precipitation assays confirmed that
Rac1 and Cdc42 activity is increased whereas RhoA activity
is reduced. Finally, relocation of p120 from the cytoplasm to
the membrane by overexpression of E-cadherin is also
sufficient to block the branching phenotype. The findings
of Anastasiadis et al. [248] are broadly similar but gain- and
loss-of-function Rac1 and Cdc42 mutants are relatively
ineffective, perhaps due to higher levels of p120 over-
expression in their cells. Again, they show that RhoA
inhibition and the interaction of p120 with E-cadherin are
mutually exclusive, thus specifically implicating the cyto-
plasmic pool of p120 in regulation of RhoA activity.
However, the effects of p120 overexpression vary according
to cell type. For example, in keratinocytes overexpression of
hysica Acta 1692 (2004) 121–144nal integrators at cell –matrix and AJs, respectively, where they have central
growth factor stimulation. Phosphorylation of FAK by SFKs at integrin
t AJ, p120 is involved in pathways which may favour either AJ assembly or
20 forms an essential link between the AJ, Rho-family GTPase activity, and
V.G. Brunton et al. / Biochimica et Biophysica Acta 1692 (2004) 121–144 135p120 activates RhoA in a Ras/PI 3-kinase-dependent man-
ner but has no effect on Rac1 or Cdc42 [183].
A potential mechanism for Rac1 and Cdc42 activation
was elucidated by Noren et al. [247] who observed the co-
immunoprecipitation and hence potential recruitment of
Vav2 by p120. A dominant negative Vav2 mutant is
sufficient to inhibit the p120-induced branching phenotype.
The mechanism for inhibition of RhoA by p120 is less clear.
Using purified proteins, p120 exhibits in vitro RhoGDI but
not RhoGAP activity [248]. p120 shares no sequence
homology with known Rho GDIs and no direct interaction
could be identified by immunoprecipitation or by yeast two-
hybrid assay. However, the Drosophila RhoA homologue
does interact directly with p120 [249].
3.4. p120 as a signal integrator at adherens junctions
p120, as a kinase substrate with the ability to influence
multiple aspects of cadherin function, is potentially in a
pivotal position to assimilate and disseminate incoming
signals. Indeed, as described above, p120 is essential both
for propagation of cadherin-activated signalling events
necessary for the formation of stable cell–cell contacts,
and yet may also be a target for tyrosine kinase-mediated
disassembly of AJs. Thus, p120 may act as a signal
integrator at AJs. In this respect, there are striking parallels
with the role of FAK at cell–matrix junctions as discussed
earlier. For example, both are regulated by Src phosphor-
ylation on multiple sites, both directly or indirectly regu-
late Rho GTPases and both apparently contribute to
adhesion assembly and disassembly via actin modulation
(Fig. 4). Thus, although the specific consequences of p120
phosphorylation remain to be elucidated, it may have an
important modulatory role, similar to that of FAK at the
cell–matrix junction.4. Cross talk between adhesion molecules and receptor
tyrosine kinases
Adhesion receptors induce intracellular signals in collab-
oration with RTKs. The integrins and cadherins do not
possess any intrinsic catalytic activity, yet they are potent
inducers of intracellular signal transduction and cellular
responses. One way in which they initiate adhesion-depen-
dent signals is by binding to a plethora of intracellular
proteins with adaptor and/or catalytic functions. Such mol-
ecules include the SFKs, which are found at both integrin
adhesions and at cadherin-dependent adhesions in epithelial
cells, and FAK, which is found exclusively at sites of
integrin-mediated attachment to the ECM. There is physical
and functional collaboration between integrins and growth
factor receptors that induces bidirectional signalling
(reviewed more extensively in Ref. [250]). It has been
known for some time that cell adhesion is required for full
activation and signalling from some RTKs, and conversely,that integrin-dependent signalling and cell migration
requires RTK activity. Furthermore, cell detachment causes
loss of responsiveness to growth factors, in part by causing
degradation of their receptors [251]. In particular, the
receptors for EGF, PDGF, VEGF and HGF, and probably
other growth factors, become phosphorylated as a result of
integrin engagement [252–257], and physical association
between EGF receptor and some integrins has been dem-
onstrated [258]. After cell attachment to ECM, there is
assembly of h1-integrin-dependent signalling complexes
containing proteins such as Src and p130Cas that lead to
ligand-independent phosphorylation of the EGF receptor
and induction of downstream signalling [259]. Although
there is overlap with EGF-induced signalling, the precise
phosphorylation events that accompany integrin-induced
activation of RTKs are not the same as when activation is
induced by ligand [259].
In addition to h1-integrins, EGF receptor (and c-Met, the
receptor for HGF) can associate with a6h4, an integrin
heterodimer that controls migration and invasion of epithe-
lial cells [260,261], at least in part by causing Fyn-depen-
dent phosphorylation of the h4 subunit [262]. Interestingly,
the adhesive properties of a6h4 may have less to do with
driving actin remodelling and migration than its ability to
promote signalling through RTKs [263]. The ability of
a6h4 to associate with ErbB-2 and promote adhesion-
independent signalling in collaboration with ErbB-2, via
PI 3-kinase and remodelling of the actin cytoskeleton, is a
major driving force for carcinoma cell invasion [264,265].
Thus, integrin subunits can stimulate intracellular signalling
and actin organisation that regulates cell migration by
activating tyrosine kinases rather than as a direct conse-
quence of their adhesive interactions.
The EGF receptor can also undergo ligand independent
activation upon recruitment to newly forming cadherin-
mediated adhesions. As with integrin adhesions, it is likely
that interactions between the cadherins and RTKs promote
assembly of signalling complexes in the vicinity of cell–
cell adhesions leading to cadherin-dependent cellular
responses. In particular, calcium-induced assembly of AJs
causes tyrosine phosphorylation of the EGF receptor and
signalling to Rac1 and ERK perhaps by increasing the
local concentration of receptor thus facilitating trans-phos-
phorylation [266,267]. N-cadherin potentiates signalling
through the FGF receptor. In this case, N-cadherin formed
a complex with the FGF receptor, preventing its ligand-
induced internalisation and resulting in sustained ERK
activation [268]. As discussed, ligand-induced activation
of EGF receptor and c-Met causes tyrosine phosphoryla-
tion of AJs components, including h-catenin, that desta-
bilizes AJs complexes and intercellular contact. Thus,
functional interplay between RTKs and cadherins is com-
plex, and tightly regulated in both directions, but in an
analogous manner to what happens at integrin adhesions,
this interplay controls both signalling output and adhesion
dynamics at AJs.
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Several lines of evidence now support the idea of cross
talk between integrins and the AJ. For example, the
disruption of AJs in colorectal cancer cells by activated
Src is dependent on integrin signalling [269]. Further-
more, KYN-2 hepatocellular carcinoma cells, which form
tight cell aggregates in the absence of integrin engage-
ment, break down AJs resulting in cell scattering when
plated on collagen or fibronectin [270]. This is associated
with elevated Src kinase activity in matrix-adherent cells
and both Src activation and disruption of AJs are pre-
vented by h1- or h5-integrin-specific antibodies. Con-
versely, integrin engagement potentiated cadherin-
mediated cell–cell adhesion and polarisation in Caco-2
cells [271].
a3h1 integrin is also implicated in the regulation of
AJs. First, unlike most integrins, a3h1 localises at, or
near, AJs [272]. Additionally, the association of AJs with
the cytoskeleton is disrupted in renal epithelial cells
from a3h1-null mice [273]. Recent work has shed light
on possible mechanisms. a3h1 constitutively associates
with CD151, a tetraspanin [274], and can form cis
engagements with urokinase-type plasminogen activator
receptor (uPAR) in an inducible manner following either
integrin activation or binding of urokinase to uPAR
[275]. The interaction of a3h1 integrin and uPAR in
renal epithelial cells results in sustained Src activation
and is sufficient to cause disruption of AJs and in-
creased motility [276]. Cell–cell adhesion is rescued by
pharmacological inhibition of Src or by co-expression of
a dominant negative Src mutant. A novel pathway link-
ing integrin-signalling via Src to specific gene transcrip-
tion events appears to be involved since transcription of
several genes is altered with a reduction in E-cadherin,
h-catenin and g-catenin and an increase in SLUG, a
transcriptional repressor known to inhibit E-cadherin
transcription that is associated with the epithelial–mes-
enchymal transition [277].
In contrast, a3h1 integrin appears to act as a positive
regulator of AJ stability when associated with CD151 [278],
since interfering with this interaction results in h-catenin
phosphorylation and reduced cadherin-mediated adhesion.
This may reflect diminished phosphatase activity as the
a3h1/CD151 interaction is necessary both for PTPA expres-
sion and for its stable recruitment to AJs as part of multi-
molecular complex containing PKChII and the scaffolding
protein RACK1.
Thus, there is clearly cross talk between integrins and
cadherins which may enhance or suppress adhesion. Such
cross talk is likely to be essential for the coordinated
changes in cell–cell and cell–matrix interactions during
processes such as embryogenesis and wound healing, and is
also likely to be involved in the acquisition of the invasive
phenotype in cancer.6. Future perspectives
There is no doubt that coordination of signals from
adhesion receptors and RTKs, often by non-receptor tyro-
sine kinases linking to the actin regulatory machinery, is at
the heart of cellular responses to extracellular cues. One of
the emerging themes is the coordination of actin/adhesion
dynamics and signalling output from adhesion sites. There
is clearly a complex, and probably reciprocal, relationship
between non-receptor tyrosine kinases of the Src and Abl
families and regulation of actin/adhesion assembly and
turnover. At the same time, these tyrosine kinases are
equipped to control a diverse range of biological functions,
including transducing signals from both growth factor- and
adhesion-receptors. They therefore have a clear role in
coordinating organisation of the actin cytoskeleton with
growth responses. The tight and complex control of signal-
ling upstream and downstream of the intracellular tyrosine
kinases is testimony to the importance, and pivotal nature,
of their activities. Together with their adhesion receptor
partners, the tyrosine kinases and actin regulators allow
three-way relaying of information that control the basic
properties of normal cells. Of course, there are many
examples of altered expression and/or activity of each of
the components of this complex circuitry in cancer cells, and
dysfunction of these is often associated with the malignant
phenotype. Cancer cells exhibit altered growth properties
and survival, as well as aberrant cytoskeletal organisation
associated with epithelial/mesenchymal plasticity and cell
migration. The particular cancer involvement of integrin and
cadherin changes, receptor tyrosine kinases like EGF recep-
tor and ErbB-2, the Src and Abl families of non-receptor
tyrosine kinases, as well as downstream effectors including
FAK, is well documented [279–286]. In addition, many of
the Rho GTPases, their regulators and downstream effectors
are also implicated in cancer development [287,288]. The
best evidence to date that activators of the Arp2/3 complex
are involved in tumour progression is the link between
overexpression of cortactin and a more motile invasive
phenotype, although there are also reports of N-WASP up-
regulation and mutations in Scar3 in tumour cells [289,290].
So although the mechanisms involved in misregulation of
the actin nucleation apparatus are not yet fully understood,
its fundamental nature and dysfunction of upstream regu-
lators implies that there may also be disruption of these
pathways during tumourigenesis.
As mentioned in this review, and elsewhere, a great deal
is now known about the functional interplay between
adhesion receptors, tyrosine kinases and actin modulators.
However, there are still huge gaps in our knowledge that
require continued investigation; in particular, how the tem-
poral and spatial integration of signals from both adhesion
receptors and tyrosine kinases that control cell fate are
regulated. Future progress in understanding the complexities
of adhesion receptor biology, and the associated circuitry
that links adhesion signalling to other cell responses,
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new technologies have opened up powerful new avenues of
research. For example, the use of fluorescent probes and
new microscopic methods (such as FRET and FLIM),
coupled with the development of protein activity biosensors,
will allow amazing visual insights into spatial regulation of
particular proteins and protein complexes in real time. In
addition, the arrival of technologies such as gene expression
profiling, bioinformatics, proteomics and RNA interference,
coupled to use of good cell model systems and genetically
tractable model organisms, will reveal yet more molecular
detail of the way in which cells respond to their environ-
ment. We have little doubt that what will be revealed is yet
further complexity, and perhaps the major challenge that lies
ahead is handling and integrating the vast amount of new
information. Never the less, daunting though the task, we
are moving towards a complete understanding of how cell–
environment interactions control multicellular organisms.Acknowledgements
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